← Evidence map

ArticleJournal of hepatology2019

Progression-free survival: Starting point or endpoint in advanced HCC trial design?

Richard S FinnPubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2019
2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30943425